Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that lorcaserin will be featured in multiple presentations at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society in Washington, DC. The line-up includes a late-breaking abstract oral presentation of results from BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management), a Phase 3 trial for which Arena reported positive, highly significant top-line results in September.
By medicalnewstoday.com
Leave a Reply
You must be logged in to post a comment.
- EXCLUSIVE: Sen. Olympia Snowe Explains Her Lone ‘Yes’ to Health Care Bill
- ‘Mentally-ill’ Briton faces execution in China
- Iraq approves return of small British force
- Boyzone member death cause revealed
- Clinton: Russia yet to back Iran sanctions
- ‘Herminator’ Maier calls time on skiing career
- U.S. official: Turkey’s delay of exercise political
- Arrests of 10 linked to Basque separatists
- Bomber: I regret trying to kill Thatcher
- Unable to scream because her throat had been slit